Clinical Trials

104 enrolled

Brain Neoplasms, Neoplasms

NCT05256225 2026-04-16

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

360 enrolled

Gynecologic

Neoplasms, Endometrial Neoplasms

NCT05436327 2026-04-16

Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers

Phase 1 Active not recruiting

479 enrolled

Communication, Neoplasms

NCT05470283 2026-04-16

Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma

21 enrolled

Dermatologic

Melanoma, Neoplasms

NCT05588141 2026-04-16

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

Phase 1/2 Recruiting

96 enrolled

Brain Neoplasms, Glioma, Neoplasms, Recurrence

NCT06510699 2026-04-16

PRAGMATIC

Other hematologic neoplasm

104 enrolled

Communicable Diseases, Infections, Mycoses, Neoplasms, Hematologic Neoplasms

NCT06801041 2026-04-16

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

20 enrolled

Anxiety Disorders, Depression, Neoplasms

NCT06959706 2026-04-16

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

50 enrolled

Carcinoma, Neoplasms

NCT07075185 2026-04-16

inMMyCAR

40 enrolled

LymphoidPlasma cell

Blood Protein Disorders, Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders

NCT07100730 2026-04-16

IPAX BrIGHT

50 enrolled

Brain Neoplasms, Glioblastoma, Neoplasm Recurrence, Local, Neoplasms, Central Nervous System Neoplasms

NCT07326800 2026-04-16

MAEva-MCT

190 enrolled

Phase 1/2 Not yet recruiting

Neoplasms

NCT07416188 2026-04-16

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

40 enrolled

Phase NA Not yet recruiting

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, Recurrence, Central Nervous System Neoplasms

NCT07499128 2026-04-16

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

136 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Cytokine Release Syndrome, Lymphoma, Multiple Myeloma, Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07504458 2026-04-16

QUATRO-APL

Other hematologic neoplasm

150 enrolled

Hematologic Diseases, Leukemia, Neoplasms, Leukemia, Promyelocytic, Acute, Hematologic Neoplasms

NCT07532057 2026-04-16

PR-LUNGCA-2019

Phase NA Completed

30 enrolled

Thoracic

Lung Neoplasms, Neoplasms, Small Cell Lung Carcinoma

NCT07533227 2026-04-16

FMT-CACH

Phase 2 Not yet recruiting

66 enrolled

Cachexia, Neoplasms

NCT01481532 2026-04-15

Open Label Clinical Trial of Intravenous Crotoxin Part 3

Phase 1 Not yet recruiting

24 enrolled

BreastGastrointestinalGenitourinaryGynecologicLymphoid

Neoplasms

NCT02379520 2026-04-15

HESTIA

Phase 1 Completed

32 enrolled

Neoplasms, Recurrence

NCT03935282 2026-04-15

AH-HA

Phase NA Completed

645 enrolled 43 charts

Breast Neoplasms, Cardiovascular Diseases, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Health Behavior, Endometrial Neoplasms

NCT04452825 2026-04-15

A New Psychotherapy Intervention for Older Cancer Patients

459 enrolled

Phase 3 Active not recruiting

Neoplasms

NCT04464226 2026-04-15

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

402 enrolled

Neoplasms

NCT04486378 2026-04-15

A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

327 enrolled

Neoplasms, Colorectal Neoplasms

NCT04905069 2026-04-15

SABRE

500 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT05065801 2026-04-15

GABRINOX2

162 enrolled

Neoplasms, Pancreatic Neoplasms

NCT06458036 2026-04-15

RAISE

Phase 2 Active not recruiting

13 enrolled

Head & Neck

Neoplasms, Thyroid Neoplasms

NCT06502977 2026-04-15

DeLLphi-307

32 enrolled 9 charts

EndocrineNET

Neoplasms, Neuroendocrine Tumors

NCT06634589 2026-04-15

A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

Phase 1/2 Recruiting

80 enrolled

Lymphoid

Neoplasms, Recurrence, Lymphoma, B-Cell

NCT06892158 2026-04-15

Massage Impact on Sleep in Pediatric Oncology

LymphoidOther hematologic neoplasm

70 enrolled

Neoplasms, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07005102 2026-04-15

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Phase 2/3 Recruiting

854 enrolled

Neoplasms

NCT07094204 2026-04-15

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

364 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT07216443 2026-04-15

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

MyeloidOther hematologic neoplasmOther neoplasm

80 enrolled

Acute Disease, Bone Marrow Diseases, Disease, Graft vs Host Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Precancerous Conditions, Preleukemia, Syndrome, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Disease Attributes

NCT07305740 2026-04-15

On-Trac

80 enrolled

Anxiety Disorders, Neoplasms

NCT07399652 2026-04-15

Artificial Intelligence-Guided Detection of Blood Vessels to Enhance Safety in Third-Space Endoscopic Procedures

20 enrolled

Esophageal Achalasia, Neoplasms

NCT07528547 2026-04-15

Peds Ethos

20 enrolled

Phase 1/2 Not yet recruiting

Neoplasms

NCT07529808 2026-04-15

ChefHat-001

164 enrolled

Phase 1/2 Not yet recruiting

Adenocarcinoma, Colonic Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT07530666 2026-04-15

Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia

58 enrolled

Cachexia, Neoplasms

NCT07532018 2026-04-15

DXP-106

54 enrolled

Phase 2 Active not recruiting

Neoplasms

NCT00092222 2026-04-14

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

75 enrolled

Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

NCT00119912 2026-04-14

NORCCAP

100,000 enrolled

Adenoma, Neoplasms, Colorectal Neoplasms

NCT01538550 2026-04-14

Pilot Study of a National Screening Programme for Bowel Cancer in Norway

140,000 enrolled

Adenoma, Neoplasms, Colorectal Neoplasms

NCT01580618 2026-04-14

Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy

Phase 2/3 Terminated

20 enrolled 11 charts

Thoracic

Neoplasms, Pleural Effusion

NCT02304913 2026-04-14

OralAcu

75 enrolled

Dysgeusia, Neoplasms, Taste Disorders

NCT03768336 2026-04-14

A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors

72 enrolled 8 charts

Neoplasms

NCT03956459 2026-04-14

IQversusMI

Phase NA Completed

24 enrolled

Neoplasms

NCT04928846 2026-04-14

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Phase 1 Active not recruiting

698 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT04958239 2026-04-14

A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer

151 enrolled